The board of directors of the US pharmaceutical company Silo Pharma approved the purchase of 1 million dollars worth of Bitcoin as reserve assets.

On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company's reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)